New study demonstrates significant improvements in medication adherence and 6% lower odds of 30-day readmissions at ...

When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those ...

The Emirates Drug Establishment (EDE) announced that it has authorised Inpefa (sotagliflozin), an innovative treatment for ...

Dubai, UAE: The Emirates Drug Establishment (EDE) announced that it has authorized Inpefa® (sotagliflozin), an innovative ...

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is ...

The list of health benefits from weight loss drugs is long, but they last only as long as people take them.

Stopping weight loss drugs is followed by weight regain and reversal of beneficial effects on heart and metabolic health ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

For some, these medications have led to profound weight loss and often improvements in heart health. Research published on ...

"Use of 1,4-DMAA can elevate blood pressure and could lead to cardiovascular problems, including heart attack, shortness of breath and tightening of the chest." Aniracetam isn't FDA approved for use ...